| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 33.97B | 35.38B | 35.29B | 32.58B | 31.65B | 30.59B |
| Gross Profit | 9.47B | 9.14B | 9.50B | 9.33B | 9.36B | 9.23B |
| EBITDA | 8.77B | 11.24B | 10.23B | 8.25B | 7.88B | 7.64B |
| Net Income | 3.23B | 4.44B | 4.21B | 3.13B | 3.13B | 3.02B |
Balance Sheet | ||||||
| Total Assets | 67.33B | 79.33B | 69.76B | 66.88B | 58.81B | 55.90B |
| Cash, Cash Equivalents and Short-Term Investments | 8.19B | 14.88B | 11.43B | 7.17B | 10.87B | 12.80B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 7.12B | 10.08B | 8.45B | 7.07B | 5.32B | 4.89B |
| Stockholders Equity | 60.20B | 69.25B | 61.67B | 59.81B | 53.48B | 51.01B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.02B | 2.48B | -765.00M | -961.00M | 1.06B |
| Operating Cash Flow | 0.00 | 2.66B | 4.39B | 1.14B | 524.00M | 2.20B |
| Investing Cash Flow | 0.00 | 2.00B | 1.41B | -3.81B | -1.43B | -3.25B |
| Financing Cash Flow | 0.00 | -1.71B | -1.53B | -1.03B | -1.02B | -377.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥88.26B | 11.57 | ― | 4.38% | -6.07% | 44.83% | |
73 Outperform | ¥78.54B | 14.08 | ― | 3.46% | -9.03% | -33.40% | |
69 Neutral | ¥64.69B | 10.92 | ― | 3.55% | 3.44% | 5.35% | |
68 Neutral | ¥74.39B | 20.28 | ― | 8.02% | -4.15% | -16.83% | |
65 Neutral | ¥75.71B | 16.92 | ― | 0.96% | 0.26% | 5.89% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥63.01B | 12.28 | ― | 3.64% | 4.96% | 17.55% |